Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 01, 2018
Source ID
10.1016/j.canlet.2018.07.039

Entities

People

  • Cherng-chyi Tzeng
  • Dannah R. Miller
  • Evan T Keller
  • Ming‐Fong Lin
  • Steve Caplan
  • Trey Farmer
  • Yeh-long Chen
  • Yu-shuin Chen

Organizations

  • Ministry of Science and Technology of the People's Republic of China
  • National Institutes of Health
  • United States Department of Defense
  • University of Nebraska Medical Center
  • University of Nebraska–Lincoln